Bioherent
Málaga, ES · 1 known investors
Bioherent develops label-free biosensors using integrated silicon photonics, surface chemistry, and nanomaterials for in vitro diagnostics, with its AllerWAVE tabletop analyzer and disposable cartridges detecting antibiotic allergies and anaphylaxis for hospitals and labs. It also sells custom silica nanoparticles (NanoKit) for biomedical research and licenses OEM photonic biosensor modules for third-party diagnostic and monitoring platforms.